Notes from the Doctoral Diary: 16th Annual Workshop of ISHTIP (25-26 June 2025)

/ By / Others

Namaskar, As June bade farewell, so too did the season of conferences—a rumoured rite of passage in the European academic circuit. Around this time last year, I wrote about my experience of ATRIP in Rome. This year, I return not from Rome, but from Madrid, where I had the pleasure of attending ISHTIP—the 16th Annual Workshop of the International Society for the History and Theory of Intellectual Property. Unlike most IP gatherings where doctrine reigns supreme, ISHTIP is a curious […]

Notes from the Doctoral Diary: 16th Annual Workshop of ISHTIP (25-26 June 2025) Read More »

Hear! Hear! Prizes Worth Crores for Bringing New Blood into Sickle Cell Innovation 

/ By / Innovation

Explaining the Ministry of Tribal Affairs’ initiative- Bhagwan Birsa Munda Prize for Development of Drug for Sickle Cell Disease, Arnav Kaman discusses the prize model of incentivising innovation. Arnav is a 3rd Year Law student from Rajiv Gandhi National University of Law, Punjab. He’s interested in Narratives and the Law. His previous post can be accessed here.   Hear! Hear! Prizes Worth Crores for Bringing New Blood into Sickle Cell Innovation  By Arnav Kaman In the eyes of the patent system for

Hear! Hear! Prizes Worth Crores for Bringing New Blood into Sickle Cell Innovation  Read More »

[Part II] Obiter > Ratio: The Good and Bad in the First Two American Decisions on Generative AI and Copyright

/ By / Copyright

Following the discussion on Judge Alsup and Judge Chhabria’s findings in Anthropic and Meta cases respectively on lawfulness of the acquired copy, Akshat Agrawal discusses their findings on market dilution and assesses these findings from the lens of the Indian Copyright law. Akshat is a practicing litigator working at Saikrishna and Associates. He did his LLM from Berkeley Law in 2023 specialising in IP and Tech law. His previous posts can be found here. He adds the following disclaimer: After some discussion around

[Part II] Obiter > Ratio: The Good and Bad in the First Two American Decisions on Generative AI and Copyright Read More »

[Part I] Obiter > Ratio: The Good and Bad in the First Two American Decisions on Generative AI and Copyright

/ By / Copyright

On the recent decisions by the Court in the Northern District of California on the copyright vs. Gen AI debate, Akshat Agrawal highlights the conflicting findings of the judges on fair use in this two-part post. In Part I, he examines the disagreement between the judges on the ‘lawfully acquired first copy’ requirement under the fair use exception, from the lens of the Indian Copyright law. Part II will discuss the findings on the market dilution theory. Akshat is a

[Part I] Obiter > Ratio: The Good and Bad in the First Two American Decisions on Generative AI and Copyright Read More »

SpicyIP Weekly Review (June 23- June 29)

/ By / Copyright, Patent, Trademark

And that’s a wrap on the inaugural edition of the SpicyIP Summer School! After a dynamic week packed with discussions on IP law and valuable life lessons, the first-ever SpicyIP Summer School concludes on a high note. Last week also featured a two-part post delving into the new performance metrics recently adopted by the Patent Office. Highlights of the Week First Ed. of the SpicyIP Summer School Wraps up! After a rigorous week of intense sessions on Pharma and creativity,

SpicyIP Weekly Review (June 23- June 29) Read More »

[Part II] – New Performance metrics might be in place in the IPO!

/ By / Patent

In the previous post, we had discussed the new OO 537/2025 that is allegedly in place to measure the performance of patent officials. I discussed the metrics in detail in the context of how it incentivises issuing reasoned orders in some instances, while not in other instances. In this post, I will discuss the need for a reasonableness checklist, how the metrics apply to PGO and finally what it means for patent quality. Moving towards a reasonableness checklist:  Questions need

[Part II] – New Performance metrics might be in place in the IPO! Read More »

[Part I] – New Performance metrics might be in place in the IPO!

/ By / Patent

While I was railing against the Indian Patent Office’s (IPO) Order 34/2016 in a previous post, the IPO might have silently put in place a more comprehensive point-based system to measure the performance of both Examiners and Controllers. This new Office Order (Office Order 537/2025 or OO 537/2025) overrides Order 34/2016 and takes effect from 09/05/2025. Unfortunately, this information was not made public, and I was railing at an order which might have been overruled and is not in effect.

[Part I] – New Performance metrics might be in place in the IPO! Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (June 16 – June 22)

/ By / Copyright, Others, Patent, Trademark

Starting this week with some delightful snapshots for our readers from the SpicyIP Summer School which kicked off with intriguing sessions by Murali Neelakantan and Sandeep Rathod!  Is IndiaMART a marketplace or a directory? – Post on Delhi HC’s granting of interim injunction against IndiaMART. Post on Delhi HC’s domestic injunction against Dr Reddy’s weight loss drug. Do payments for cloud computing services to AWS constitute “royalty”? – Post on Delhi HC’s judgment on the issue. This and much more

SpicyIP Weekly Review (June 16 – June 22) Read More »

Not “Well-Known” Enough? What the Bombay HC’s Decision On TikTok Tells Us About Well-Known Marks

/ By / Others, Trademark

Banned in June 2020 on the grounds of national security, popular short-form video-sharing platform TikTok is no stranger to controversy in India. Continuing this saga, last week, the Bombay High Court (“the Court”) denied recognition to the registered trademark “TikTok” as a “well-known mark” (under Rule 124, Trademark Rules, 2017). Defined in Section 2(zg) of the Trade Marks Act, 1999 (“the Act”), a “well-known trade mark” in relation to any goods or services, refers to a mark that has become

Not “Well-Known” Enough? What the Bombay HC’s Decision On TikTok Tells Us About Well-Known Marks Read More »

Panel Discussion: The Future of Affordable Biosimilars in India

/ By / Opportunities

TWN invites you to a panel discussion on the future of affordable biosimilars in India. The discussion will take place on June 23, 2025 at 3:30 PM – 5:00 PM. For more details check out their concept note below :- Panel Discussion: The Future of Affordable Biosimilars in India Biosimilars are a lifeline for patients in need of affordable, life-changing biologic therapies for conditions such as cancer, autoimmune diseases, and diabetes—especially in countries like India, where the high cost of

Panel Discussion: The Future of Affordable Biosimilars in India Read More »

Scroll to Top